Search results
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 4 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
Novavax's stock surges almost 300% in the past month
AOL· 12 hours agoNovavax stock (NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA ...
Roblox CFO sells over $2.1 million in company stock By Investing.com
Investing.com· 5 hours agoThis plan had been adopted by Guthrie on November...priced at $0.53 per share on June 5, following a...
Roblox CFO sells over $2.1 million in company stock By Investing.com
Investing.com· 5 hours agoThis plan had been adopted by Guthrie on November...priced at $0.53 per share on June 5, following a...
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
InvestorPlace· 16 hours agoVaccine maker Novavax (NASDAQ:NVAX) saw its shares jump 18% on June 5 and another 20% in pre-market...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoNEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. (“Moderna” or the “Company”) ( ...
5 Stocks Propelling S&P 500 to 25th Record High
Zacks via Yahoo Finance· 15 hours agoThe S&P 500 touches a record high for the 25th time this year, powered by technology stocks. We have highlighted five technology stocks, HPE, MRNA, AVGO,...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 4 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks· 4 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the CDC's recommendation, it will be launched in the 2024-2025 respiratory virus season.
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via Yahoo Finance· 6 days agoOn Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory...